Femme et Homme
- | Pays : -
- | Organes : -
- | Spécialités : -
Extrait
The study is designed to obtain safety and efficacy data on three dose levels of indacaterol when delivered via an SDDPI in patients with COPD. All patients will receive 1 day of treatment with each of the following: indacaterol 150 µg, once- indacaterol 300 µg, indacaterol 600 µg, placebo, and formoterol. Each treatment day will be followed by a washout-period of 1 week.
Critère d'inclusion
- Pulmonary Disease, Chronic Obstructive,COPD,Lung Diseases, Obstructive